Renal (Uworld) Flashcards
Renal vein thrombosis risk factors?
hypercoagulability: nephrotic syndrome,malignancy( particularly renal), oraql contra pills; volume depletion ( infants), trauma.
Renal vein thrombosis clinical features?
hematuria, flank or abdominal pain, elevated LDH (lactate dehydrogenase) with or without acute kidney injury, enlarged kidney on imaging.
Renal vein thrombosis diagnosis?
CT or MRI angiography, renal venography.
Renal vein thrombosis treatment?
anticoagulation, thrombolysis/thrombectomy (if AKI is present).
Renal vein thrombosis presents with?
hematuria, renovascular congestion (increased glomerular pressure), and flank pain (capsular stretch).
Renal vein thrombosis causes?
nephrotic syndrome, malignancy, and trauma ( acquired hypercoagulability).
Uretrolithiasis presentation?
acute flank pain and nausea.
ureterolithiasis stones
if less or = 5 passes spontaneously, increased oral fluid intake to ensure adequate flow of dilute urine
Alpha-blockers (ureterolithiasis)
facilitate passage of larger stones (6 - 10 mm)
urologic consultation ?
if stone is 10 or more and for refractory pain, anuria, aki, and signs of urosepsis.
nephrolithiasis presentation?
flank pain and hematuria also nausea and vomiting.
hyperoxaluria
can be caused by crohn disease or any other small intestines disease that leads to fat malabsorption.
Symptomatic hyperoxaluria
the result of increased oxalate absorption in the gut ( ca with fat instead of ca binding to oxalate) also decreased bile salts reabsorption in the small intestine damage the colonic mucosa and increase oxalate absorption.
Diabetic nephropathy
the early stages of diabetic nephropathy are characterized by a period of glomerular hyperfiltration involving an increase in the fraction of plasma that is filtered by each glomerulus. this period may be clinically recognized by slightly reduced serum creatinine as well as the onset of moderately increased albuminuria ( 30 - 300 mg/g).
Glomerular filtration in early DN?
primarily driven by an increase in hormonal mediators that favor afferent arteriole vasodilation ( natriuretic peptides, prostaglandins) and efferent arteriole vasoconstriction ( angiotensin 2) this causes an increase in glomerular hydrostatic pressure which increase the glomerular filtration rate, however, it also stimulates a sclerotic response in the glomerular capillaries and facilitates the gradual progression of DN.